PET-MRI of Reward System in Parkinson's Disease With RBD

Abroad (travel likely)Recruiting

Conditions

Parkinson's Disease (PD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHU Clermont-Ferrand, Clermont-Ferrand,, Clermont-Ferrand, France
Contact: Study coordinator (Lise LACLAUTRE) · promo_interne_drci@chu-clermontferrand.fr · +33473754963
Contact: Principal Investigator (Charlotte BEAL)
CH Le Puy en Velay, Le Puy-en-Velay, France
Contact: Principal Investigator (Jeremy DASSA)
CHRU Lyon, Lyon, France
Contact: Principal Investigator (Stéphane THOBOIS)

Study leads

Charlotte BEAL
Principal Investigator
University Hospital, Clermont-Ferrand

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)

Parkinson's Disease (PD)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Sacramento, United States

Attention and Eye Movement in Parkinson's Disease

Essential Tremor · Parkinson's Disease (PD) · Dystonias

Abroad (travel likely)Recruiting

Omaha, United States

Accelerated TMS for Freezing of Gait in Parkinson's Disease

Parkinson's Disease (PD)

Abroad (travel likely)Recruiting

Charleston, United States

Clozapine-related Immunodeficiency in Parkinsons Disease

Clozapine · Parkinson's Disease (PD) · Immunodeficiency

Abroad (travel likely)RecruitingPHASE4

Salouël, France